A spokesman for Purdue Pharma issued a statement noting that its brand-name product, OxyContin, "accounts for only 2 percent of the opioid analgesic prescriptions nationally, but we are an industry leader in the development of abuse-deterrent technology and advocating for the use of prescription drug monitoring programs.